Andere Kunden interessierten sich auch für
![New multi-factorial therapies for ataxic cerebral palsy]( "New multi-factorial therapies for ataxic cerebral palsy")
New multi-factorial therapies for ataxic cerebral palsy30,99 €![Development of Mucoadhesive Buccal Patches of Flurbiprofen]( "Development of Mucoadhesive Buccal Patches of Flurbiprofen")
Development of Mucoadhesive Buccal Patches of Flurbiprofen38,99 €![Development of Mucoadhesive Buccal Patch of Timolol Maleate]( "Development of Mucoadhesive Buccal Patch of Timolol Maleate")
Development of Mucoadhesive Buccal Patch of Timolol Maleate40,99 €![Drop Foot Correction on Uneven Ground using Peroneal Nerve Stimulation]( "Drop Foot Correction on Uneven Ground using Peroneal Nerve Stimulation")
Drop Foot Correction on Uneven Ground using Peroneal Nerve Stimulation32,99 €![Chemodosimetry of Invivo Tumor Liposome/Drug Concentration using MRI]( "Chemodosimetry of Invivo Tumor Liposome/Drug Concentration using MRI")
Chemodosimetry of Invivo Tumor Liposome/Drug Concentration using MRI51,99 €![Function Approximation Using Generalized Adalines]( "Function Approximation Using Generalized Adalines")
Function Approximation Using Generalized Adalines32,99 €![DETERMINATION OF CD4+ T-CELLS USING DIFFERENT SYSTEMS]( "DETERMINATION OF CD4+ T-CELLS USING DIFFERENT SYSTEMS")
DETERMINATION OF CD4+ T-CELLS USING DIFFERENT SYSTEMS32,99 €
Glipizide is a second-generation sulfonylurea that can acutely lower the blood glucose level in humans and is typically prescribed to treat type II Diabetes. Its short biological half-life necessitates that it be administered in two or three doses of 2.5 to 10 mg per day and the problem associated with gastrointestinal disturbances, attempts have been made to develop sustained release product. In the present investigation mucoadhesive beads of Glipizide were formulated employing sodium alginate,carbapol 974P and SCMC. The prepared formulations were evaluated for physical parameter, mucoadhesive properties, in vitro wash-off test and in vivo test by Folin-wv method. so formulation may be replaced by novel mucoadhesive beads with release and absorption phase of longer periods.